Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral venous thrombosis: an update.

Marie-Germaine Bousser1, José M Ferro

  • 1AP-HP Hôpital Lariboisière-Service de Neurologie, Paris, France. mg.bousser@lrb.aphp.fr

The Lancet. Neurology
|January 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asundexian for Secondary Stroke Prevention.

The New England journal of medicine·2026
Same author

Impact of anaemia severity on functional outcome in patients with cerebral venous thrombosis: a DOAC-CVT substudy.

European stroke journal·2026
Same author

Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention.

European stroke journal·2026
Same author

Potential and limitations of computed tomography images as predictors of the outcome of ischemic stroke events: a review.

Frontiers in stroke·2026
Same author

Quality of life after decompressive surgery for severe cerebral venous thrombosis.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Seizures after decompressive surgery for cerebral venous thrombosis.

Journal of neurology·2025

Cerebral venous thrombosis (CVT) is a rare stroke type, diagnosed via advanced MRI. Early heparin treatment is standard, with other options for severe cases, offering a generally good prognosis.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Radiology

Background:

  • Cerebral venous thrombosis (CVT) is a rare cerebrovascular disease affecting all ages, including neonates, accounting for 0.5% of all strokes.
  • Advances in neuroimaging have significantly improved the understanding and early diagnosis of CVT.
  • CVT is recognized as a non-septic condition with diverse presentations, etiologies, and typically favorable outcomes.

Purpose of the Study:

  • To review the current understanding of cerebral venous thrombosis.
  • To highlight diagnostic modalities and treatment strategies for CVT.
  • To emphasize the importance of early diagnosis and appropriate management.

Main Methods:

  • Magnetic Resonance Imaging (MRI) using T1, T2, FLAIR, and T2* sequences.

Related Experiment Videos

  • Magnetic Resonance Angiography (MRA) for vascular assessment.
  • Analysis of D-dimer levels in suspected CVT cases.

    • Main Results:

    • MRI with MRA is the gold standard for diagnosing CVT.
    • Elevated D-dimer levels are common, but normal levels do not exclude CVT, especially with isolated headache.
    • Heparin is the primary treatment, with interventions like thrombolysis or thrombectomy reserved for severe instances.

    Conclusions:

    • CVT is more common than previously thought and presents variably.
    • Early diagnosis through advanced neuroimaging is crucial for effective management.
    • While heparin is first-line, aggressive treatments may be necessary in complex cases, generally leading to good outcomes.